These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 7676646

  • 1. Resistance to transformation by insertionally activated c-erbB is a dominant phenotype in fibroblasts.
    Carter TH, Dominguez N, Zeng L, Kung HJ.
    Virology; 1995 Sep 10; 212(1):277-83. PubMed ID: 7676646
    [Abstract] [Full Text] [Related]

  • 2. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ, Maihle NJ.
    Exp Cell Res; 2002 Apr 15; 275(1):9-16. PubMed ID: 11925101
    [Abstract] [Full Text] [Related]

  • 3. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
    Rapp UR, Troppmair J, Beck T, Birrer MJ.
    Oncogene; 1994 Dec 15; 9(12):3493-8. PubMed ID: 7970709
    [Abstract] [Full Text] [Related]

  • 4. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
    McCubrey JA, Shelton JG, Steelman LS, Franklin RA, Sreevalsan T, McMahon M.
    Oncogene; 2004 Oct 14; 23(47):7810-20. PubMed ID: 15361836
    [Abstract] [Full Text] [Related]

  • 5. A role for Ras in v-Crk transformation.
    Greulich H, Hanafusa H.
    Cell Growth Differ; 1996 Nov 14; 7(11):1443-51. PubMed ID: 8930393
    [Abstract] [Full Text] [Related]

  • 6. Defective v-erbB genes can be complemented by v-erbA in erythroblast and fibroblast transformation.
    Jansson M, Beug H, Gray C, Graf T, Vennström B.
    Oncogene; 1987 May 14; 1(2):167-73. PubMed ID: 2830578
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transformation of erythroid progenitors by viral and cellular tyrosine kinases.
    Beug H, Schroeder C, Wessely O, Deiner E, Meyer S, Ischenko ID, Hayman MJ.
    Cell Growth Differ; 1995 Aug 14; 6(8):999-1008. PubMed ID: 8547228
    [Abstract] [Full Text] [Related]

  • 13. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP, Jove R.
    Cell Growth Differ; 1997 Dec 14; 8(12):1267-76. PubMed ID: 9419415
    [Abstract] [Full Text] [Related]

  • 14. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
    Bader AG, Hartl M, Bister K.
    Virology; 2000 Apr 25; 270(1):98-110. PubMed ID: 10772983
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.